CIK 0000842023
- Large accelerated filer
BIO-TECHNE Corp
Sign in to watch- Ticker
- TECH
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- MN
- Entity type
- Operating
- EIN
- 411427402
- Phone
- +1 612-379-8854
- Business address
- 614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
- Former names
- TECHNE CORP /MN/
- 4 Open-market sale Director sold 100 shares at $110.59 ($11,059)
- 4 Open-market sale Director sold 100 shares at an average $101.15 ($10,115)
- 4 Shares withheld for taxes Chief Financial Officer gave up 800 shares (to pay taxes)
- 4 Open-market sale Director sold 100 shares at an average $107.77 ($10,777)
- 4 Open-market sale Director sold 100 shares at $102.60 ($10,260)
- 4 Option exercise Senior V.P. Protein Platforms acquired 1,667 shares (option exercise)
- 4 Open-market sale Director sold 100 shares at $103.57 ($10,357)
- 4 Open-market sale Director sold 100 shares at $108.92 ($10,892)
- 4 Open-market sale Director sold 1,000 shares at $106.73 ($106,733)
- 4 Open-market sale Director sold 100 shares at $105.75 ($10,575)
- 4 Open-market sale Director sold 100 shares at $104.71 ($10,471)
- 4 Grant or award Director acquired 914 shares (grant or award)
- 4 Grant or award Director acquired 914 shares (grant or award)
- 4 Grant or award Director acquired 914 shares (grant or award)
- 4 Grant or award Director acquired 914 shares (grant or award)
- 4 Grant or award Director acquired 914 shares (grant or award)
- 4 Grant or award Director acquired 914 shares (grant or award)
- 4 Grant or award Director acquired 914 shares (grant or award)
- 4 Open-market sale Director sold 100 shares at $108.91 ($10,891)
- 4 Open-market sale SVP Clinical Controls sold 524 shares at $110.50 ($57,904)
Page 19 of 35 · 695 filings